Correlation Between Abivax SA and Pharnext

Can any of the company-specific risk be diversified away by investing in both Abivax SA and Pharnext at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abivax SA and Pharnext into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abivax SA and Pharnext SA, you can compare the effects of market volatilities on Abivax SA and Pharnext and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abivax SA with a short position of Pharnext. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abivax SA and Pharnext.

Diversification Opportunities for Abivax SA and Pharnext

0.0

Correlation Coefficient

Abivax SA  Pharnext

Pay attention - limited upside

The 3 months correlation between Abivax and Pharnext is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abivax SA and Pharnext SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharnext SA and Abivax SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abivax SA are associated (or correlated) with Pharnext. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharnext SA has no effect on the direction of Abivax SA i.e., Abivax SA and Pharnext go up and down completely randomly.

Pair Corralation between Abivax SA and Pharnext

If you would invest  0.02  in Pharnext SA on September 29, 2024 and sell it today you would earn a total of  0.00  from holding Pharnext SA or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Abivax SA  vs.  Pharnext SA

Abivax SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Abivax SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pharnext SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharnext SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pharnext is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Abivax SA and Pharnext

The main advantage of trading using opposite Abivax SA and Pharnext positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abivax SA position performs unexpectedly, Pharnext can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharnext will offset losses from the drop in Pharnext's long position.

The idea behind Abivax SA and Pharnext SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.